Transurethral injection of polyacrylamide hydrogel (Bulkamid?) for the treatment of female stress or mixed urinary incontinence

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F14%3AE0104034" target="_blank" >RIV/00843989:_____/14:E0104034 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.ejogrb.2014.03.033" target="_blank" >http://dx.doi.org/10.1016/j.ejogrb.2014.03.033</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.ejogrb.2014.03.033" target="_blank" >10.1016/j.ejogrb.2014.03.033</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Transurethral injection of polyacrylamide hydrogel (Bulkamid?) for the treatment of female stress or mixed urinary incontinence

Popis výsledku v původním jazyce

OBJECTIVE: The aim of this study was to evaluate the cure effect of a transurethral injection (TUI) of Bulkamid(?) for female urodynamic stress (USI) and stress-predominant mixed urinary incontinence. The hypothesis was that the cure effect of Bulkamid(?) is positive in patients who have undergone previous unsuccessful anti-incontinence surgery and in patients with ISD (Intrinsic Sphincter Deficiency). STUDY DESIGN: This retrospective clinical study was performed on 52 patients for whom previous anti-incontinence surgery had failed (n=40) and on patients with ISD. Five patients had a reinjection of Bulkamid(?). The efficacy of TUI was evaluated an average of 22 months (minimum - 6 months, maximum - 50 months) after the procedure. Subjective assessmentof the leakage of urine was based on the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-UI SF). Objective assessment of leakage of urine was assessed by the cough test. The cure effect of procedures was evalua

Název v anglickém jazyce

Transurethral injection of polyacrylamide hydrogel (Bulkamid?) for the treatment of female stress or mixed urinary incontinence

Popis výsledku anglicky

OBJECTIVE: The aim of this study was to evaluate the cure effect of a transurethral injection (TUI) of Bulkamid(?) for female urodynamic stress (USI) and stress-predominant mixed urinary incontinence. The hypothesis was that the cure effect of Bulkamid(?) is positive in patients who have undergone previous unsuccessful anti-incontinence surgery and in patients with ISD (Intrinsic Sphincter Deficiency). STUDY DESIGN: This retrospective clinical study was performed on 52 patients for whom previous anti-incontinence surgery had failed (n=40) and on patients with ISD. Five patients had a reinjection of Bulkamid(?). The efficacy of TUI was evaluated an average of 22 months (minimum - 6 months, maximum - 50 months) after the procedure. Subjective assessmentof the leakage of urine was based on the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-UI SF). Objective assessment of leakage of urine was assessed by the cough test. The cure effect of procedures was evalua

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FP - Ostatní lékařské obory

OECD FORD obor

—

Projekt

<a href="/cs/project/NT13509" target="_blank" >NT13509: Intrauretrální aplikace Bulkamidu u žen s těžkou inkontinencí moči na podkladě insuficience vnitřního svěrače uretry.</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

European journal of obstetrics & gynecology and reproductive biology

ISSN

0301-2115

e-ISSN

—

Svazek periodika

178

Číslo periodika v rámci svazku

n. July

Stát vydavatele periodika

NL - Nizozemsko

Počet stran výsledku

4

Strana od-do

"p. 199-202"

Kód UT WoS článku

000339036600037

EID výsledku v databázi Scopus

—